Get Niagen Bioscience alerts:Niagen Bioscience, Inc. (NASDAQ:NAGE – Free Report) – Investment analysts at Roth Capital cut their Q1 2026 earnings estimates for Niagen Bioscience in a research report issued on Wednesday, October 1st. Niagen Bioscience (NASDAQ:NAGE – Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. Niagen Bioscience had a net margin of 15.24% and a return on equity of 23.12%. Check Out Our Latest Stock Report on NAGENiagen Bioscience Trading Down 6.5%Niagen Bioscience stock opened at $7.38 on Thursday. Further ReadingReceive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.